T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

However, because the peptide alone does not trigger a sufficiently strong immune response, the researchers added a so-called ...

The publication explains ... New Phase of the Immune Response Uncovered Apr. 10, 2025 — A team has identified a previously unknown phase of the immune response. The results challenge long ...

Discover a study where researchers identified a marked decline in monocyte function and maturation during the ...

Tetanus-diphtheriaa-acellular pertussis–inactivated polio virus vaccination during pregnancy is safe and boosts ...

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...

The ongoing phase 2 trial, which combines EVX-01 with ... EVX-01's effectiveness in triggering a tumor-specific immune response, surpassing previous vaccine candidates. When will the two-year ...

EVX-01 vaccine targets triggered a tumor-specific immune response, a substantially higher frequency than what has been reported for other similar vaccine candidatesThe data underscores the precision ...

However, because the peptide alone does not trigger a sufficiently strong immune response, the researchers added a so-called agonist in both vaccination phases to further activate the immune cells ...

New immune data from the ongoing phase 2 trial with EVX-01 will be presented ... 01 vaccine targets triggered a tumor-specific immune response. In earlier interim analyses presented at the ASCO ...